Thread

Claude discovers a novel enzyme system with CRISPR-like repeats

780 points · 805 comments · raahelb

evolarjun · 1790192734 · focus · HN ↗
It is odd (or maybe not) that they decided to publish a marketing whitepaper rather than a more traditional journal submission + preprint. The work does appear to be sufficient for a publication, though there's a good chance a reviewer will rip into them for some of the assertions they make, but given the topic I'm sure the paper will be accepted regardless.
The market for entry-level programmers has already declined, but at least they were somewhat in demand and made reasonable salaries. Now what happens to post-docs who already make almost nothing and often get treated like crap?
1. torginus · 1790203513 · focus · HN ↗
  Why do you think they're going to be treated badly? Right now, I think it's kinda accepted that the people best suited to directing AI for programming tasks are programmers - only we operate at a higher level.
  Claude's going to be a similar productivity booster to researchers and postdocs.
  I'd be totally lost talking to an AI about biochemistry.

Unofficial Hacker News client; not affiliated with Y Combinator.